Logo image of EMCGR

EMBRACE CHANGE ACQ-RIGHTS (EMCGR) Stock Price, Quote, News and Overview

NASDAQ:EMCGR - Nasdaq - KYG3034H1415 - Currency: USD

0.12  -0.02 (-11.11%)

Fundamental Rating

1

EMCGR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. EMCGR has a bad profitability rating. Also its financial health evaluation is rather negative. EMCGR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EMCGR was profitable.
In the past year EMCGR has reported a negative cash flow from operations.
EMCGR Yearly Net Income VS EBIT VS OCF VS FCFEMCGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1M -1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 6.46%
ROE 8.32%
ROIC N/A
ROA(3y)1.61%
ROA(5y)N/A
ROE(3y)1.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMCGR Yearly ROA, ROE, ROICEMCGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 4

1.3 Margins

EMCGR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMCGR Yearly Profit, Operating, Gross MarginsEMCGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for EMCGR has been reduced compared to 1 year ago.
The debt/assets ratio for EMCGR is higher compared to a year ago.
EMCGR Yearly Shares OutstandingEMCGR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
EMCGR Yearly Total Debt VS Total AssetsEMCGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.49, we must say that EMCGR is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.05 indicates that EMCGR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACCN/A
EMCGR Yearly LT Debt VS Equity VS FCFEMCGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.01 indicates that EMCGR may have some problems paying its short term obligations.
EMCGR has a Quick Ratio of 0.01. This is a bad value and indicates that EMCGR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
EMCGR Yearly Current Assets VS Current LiabilitesEMCGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for EMCGR have decreased by -8.05% in the last year.
EPS 1Y (TTM)-8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMCGR Yearly Revenue VS EstimatesEMCGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
EMCGR Yearly EPS VS EstimatesEMCGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EMCGR is valuated cheaply with a Price/Earnings ratio of 0.52.
The average S&P500 Price/Earnings ratio is at 29.63. EMCGR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.52
Fwd PE N/A
EMCGR Price Earnings VS Forward Price EarningsEMCGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMCGR Per share dataEMCGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMCGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMBRACE CHANGE ACQ-RIGHTS

NASDAQ:EMCGR (2/21/2025, 8:15:39 PM)

0.12

-0.02 (-11.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners50.85%
Inst Owner Change-89.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap542.40K
AnalystsN/A
Price TargetN/A
Short Float %0.07%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.52
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)0.23
EY191.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS4.43
TBVpS4.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.46%
ROE 8.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.61%
ROA(5y)N/A
ROE(3y)1.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.49
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5663.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5663.3%
OCF growth 3YN/A
OCF growth 5YN/A